Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1784532
Max Phase: Preclinical
Molecular Formula: C46H67N7O13
Molecular Weight: 926.08
Molecule Type: Small molecule
Associated Items:
ID: ALA1784532
Max Phase: Preclinical
Molecular Formula: C46H67N7O13
Molecular Weight: 926.08
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Arylomycin B-C16
Synonyms from Alternative Forms(1):
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)N(C)[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)Cc2cc(c(O)c([N+](=O)[O-])c2)-c2cc1ccc2O
Standard InChI: InChI=1S/C46H67N7O13/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-38(56)51(4)36(27-54)44(61)48-28(2)42(59)47-26-39(57)52(5)40-31-20-21-37(55)32(25-31)33-22-30(24-35(41(33)58)53(65)66)23-34(46(63)64)50-43(60)29(3)49-45(40)62/h20-22,24-25,28-29,34,36,40,54-55,58H,6-19,23,26-27H2,1-5H3,(H,47,59)(H,48,61)(H,49,62)(H,50,60)(H,63,64)/t28-,29+,34+,36-,40+/m1/s1
Standard InChI Key: HHIDVQDFBNNEET-WCWBUJDUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 926.08 | Molecular Weight (Monoisotopic): 925.4797 | AlogP: 3.72 | #Rotatable Bonds: 24 |
Polar Surface Area: 298.15 | Molecular Species: ACID | HBA: 12 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.16 | CX Basic pKa: | CX LogP: 3.90 | CX LogD: -0.56 |
Aromatic Rings: 2 | Heavy Atoms: 66 | QED Weighted: 0.04 | Np Likeness Score: 0.39 |
1. Roberts TC, Smith PA, Romesberg FE.. (2011) Synthesis and biological characterization of arylomycin B antibiotics., 74 (5): [PMID:21545107] [10.1021/np200163g] |
2. Tan YX, Romesberg FE. (2012) Latent antibiotics and the potential of the arylomycins for broad-spectrum antibacterial activity, 3 (8): [10.1039/C2MD20043K] |
Source(1):